Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System
VERITAS
VERITAS - A Study to Demonstrate the Value of Multiple Modalities Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
1 other identifier
interventional
97
1 country
15
Brief Summary
To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Jan 2018
Typical duration for not_applicable chronic-pain
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2017
CompletedFirst Posted
Study publicly available on registry
August 16, 2017
CompletedStudy Start
First participant enrolled
January 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2020
CompletedResults Posted
Study results publicly available
March 16, 2020
CompletedApril 1, 2021
March 1, 2021
1 year
August 15, 2017
January 21, 2020
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Subjects With 50% or Greater Reduction in Overall Pain From Baseline
3 months post activation
Study Arms (1)
Spinal Cord Stimulation
EXPERIMENTALSpectra WaveWriter SCS System
Interventions
Multiple modalities of stimulation therapy
Eligibility Criteria
You may qualify if:
- Chronic pain of the trunk and/or limbs
- years of age or older at time of enrollment
- Willing and able to comply with all protocol-required procedures and assessments/evaluations provided in English
- Willing and capable of giving informed consent
You may not qualify if:
- Any pain-related diagnosis or medical/psychological condition that, in the clinician's best judgment, might confound reporting of study outcomes
- Significant cognitive impairment that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
- Current systemic infection, or local infection in close proximity to the anticipated surgical field
- Breast-feeding, pregnant or planning to get pregnant during the course of the study or not using adequate contraception
- Previous spinal cord stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)
- Participating, or intends to participate, in another clinical trial that may influence the data that will be collected for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Neurovations
Napa, California, 94558, United States
Louis J. Raso, MD, PA
Jupiter, Florida, 33477, United States
Florida Pain Clinic
Ocala, Florida, 34471, United States
Forest Health Medical Center
Ypsilanti, Michigan, 48198, United States
Mercy Medical Research Institute
Springfield, Missouri, 65804, United States
University of Rochester
Rochester, New York, 14618, United States
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, 27103, United States
University Hospitals of Cleveland
Cleveland, Ohio, 44106, United States
Western Reserve Spine and Pain Institute
Kent, Ohio, 44240, United States
Toledo Clinic
Toledo, Ohio, 43623, United States
West Chester Hospital, LLC
West Chester, Ohio, 45069, United States
Pacific Sports and Spine, LLC
Eugene, Oregon, 97401, United States
Spine Team Texas
Rockwall, Texas, 75032, United States
Swedish Neuroscience Institute
Seattle, Washington, 98122, United States
Advanced Pain Management Appleton
Appleton, Wisconsin, 54913, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director of Clinical Sciences
- Organization
- Boston Scientific
Study Officials
- STUDY DIRECTOR
Roshini Jain
Boston Scientific Corporation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2017
First Posted
August 16, 2017
Study Start
January 9, 2018
Primary Completion
January 9, 2019
Study Completion
March 10, 2020
Last Updated
April 1, 2021
Results First Posted
March 16, 2020
Record last verified: 2021-03